Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.

RCPT

RECEPTOS, INC. (RCPT)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:RCPT
DataOraFonteTitoloSimboloCompagnia
03/06/201423:29Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:RCPT(MM)
30/05/201400:44Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:RCPT(MM)
14/05/201422:13Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:RCPT(MM)
14/05/201422:04Edgar (US Regulatory)Automatic Shelf Registration Statement of Securities of Well-known Seasoned Issuers (s-3asr)NASDAQ:RCPT(MM)
12/05/201423:17Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:RCPT(MM)
12/05/201414:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RCPT(MM)
12/05/201414:00GlobeNewswire Inc.Receptos Reports First Quarter 2014 Financial ResultsNASDAQ:RCPT(MM)
07/05/201414:00GlobeNewswire Inc.Receptos to Hold First Quarter 2014 Financial Results Conference Call and WebcastNASDAQ:RCPT(MM)
06/05/201414:00GlobeNewswire Inc.Receptos to Present at Bank of America Merrill Lynch 2014 Health Care ConferenceNASDAQ:RCPT(MM)
01/05/201414:00GlobeNewswire Inc.Receptos to Present at Deutsche Bank Securities Annual Healthcare ConferenceNASDAQ:RCPT(MM)
28/04/201411:00GlobeNewswire Inc.Receptos to Deliver Scientific Presentations Regarding RPC1063 at the 2014 American Academy of Neurology (AAN) Annual Meeting...NASDAQ:RCPT(MM)
23/04/201422:57Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:RCPT(MM)
23/04/201422:55Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:RCPT(MM)
14/04/201422:56GlobeNewswire Inc.Receptos Announces Appointment of Mary Lynne Hedley, Ph.D. as DirectorNASDAQ:RCPT(MM)
09/04/201414:00PR Newswire (US)Healthcare Companies Report Regulatory Affirmations, MPA Inspections, Enrollment in Trials, Stock Movements - Analyst Notes o...NASDAQ:RCPT(MM)
20/03/201413:00GlobeNewswire Inc.Receptos to Present at BioCentury Future Leaders ConferenceNASDAQ:RCPT(MM)
18/03/201413:00PR Newswire (US)Initiation of Clinical Trials, Completed Acquisitions, Financial Results, and Earnings Release Schedules - Analyst Notes on C...NASDAQ:RCPT(MM)
06/03/201422:44Edgar (US Regulatory)Annual Report (10-k)NASDAQ:RCPT(MM)
05/03/201422:05GlobeNewswire Inc.Receptos Reports Fourth Quarter and Year End 2013 Operational and Financial ResultsNASDAQ:RCPT(MM)
27/02/201414:00GlobeNewswire Inc.Receptos to Hold Fourth Quarter and Year End 2013 Financial Results Conference Call and WebcastNASDAQ:RCPT(MM)
24/02/201415:00PR Newswire (US)Sheila Gujrathi, M.D., Joins Ambrx Board of DirectorsNASDAQ:RCPT(MM)
20/02/201422:18Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:RCPT(MM)
14/02/201422:33Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:RCPT(MM)
14/01/201415:46GlobeNewswire Inc.Receptos Announces Closing of Underwritten Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purch...NASDAQ:RCPT(MM)
09/01/201403:41GlobeNewswire Inc.Receptos Announces Pricing of Underwritten Public Offering of Common StockNASDAQ:RCPT(MM)
06/01/201422:05GlobeNewswire Inc.Receptos Begins Enrollment of Phase 3 Trial of RPC1063 in Relapsing Multiple SclerosisNASDAQ:RCPT(MM)
06/01/201422:05GlobeNewswire Inc.Receptos Announces Proposed Underwritten Public Offering of Common StockNASDAQ:RCPT(MM)
10/12/201322:05GlobeNewswire Inc.Receptos and Ono Pharmaceuticals Expand Collaboration Agreement to Include Transfer of Receptos GPCR Technology PlatformNASDAQ:RCPT(MM)
05/12/201314:00GlobeNewswire Inc.Receptos to Initiate Phase 3 Trial of RPC1063 in Relapsing Multiple SclerosisNASDAQ:RCPT(MM)
26/11/201314:00GlobeNewswire Inc.Christian Waage Appointed General Counsel of ReceptosNASDAQ:RCPT(MM)
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:RCPT
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network